Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants

Clinical trial NCT00879827 · COMPLETED

Trial details

NCT number: NCT00879827
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Poliomyelitis Hepatitis B Tetanus Acellular Pertussis

Start date: 2000-09-01
Primary completion: 2001-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.